Pfizer Inc PFE
📋 Company Profile
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1944-01-17 |
| Shares Out. | 5,699,440,000 |
| Website | pfizer.com/ ↗ |
| Phone | 12127332323 |
| Employees | 75,000 |
| Revenue | $14.45B |
| Gross Profit | $10.90B |
| Net Income | $2.70B |
| Free Cash Flow | $9.49B |
| Total Assets | $207.62B |
| Total Liabilities | $117.21B |
| Equity | $90.40B |
About Pfizer Inc
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Pfizer Inc is a publicly traded company under the ticker symbol PFE on the NEW YORK STOCK EXCHANGE, INC., operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
36 analysts (2026-07-01)

